BR8900697A - Proteina de antigeno circunsporozoitico;composicao de vacina;composicao utilizavel para o diagnostico de malaria em seres humanos;processo para a producao da proteina de antigeno circunsporozoitico;sistema de vetor baculovirus-celula de inseto - Google Patents
Proteina de antigeno circunsporozoitico;composicao de vacina;composicao utilizavel para o diagnostico de malaria em seres humanos;processo para a producao da proteina de antigeno circunsporozoitico;sistema de vetor baculovirus-celula de insetoInfo
- Publication number
- BR8900697A BR8900697A BR898900697A BR8900697A BR8900697A BR 8900697 A BR8900697 A BR 8900697A BR 898900697 A BR898900697 A BR 898900697A BR 8900697 A BR8900697 A BR 8900697A BR 8900697 A BR8900697 A BR 8900697A
- Authority
- BR
- Brazil
- Prior art keywords
- antigen protein
- circumsporozoitic
- circumsosozoitic
- production
- human beings
- Prior art date
Links
- 102000036639 antigens Human genes 0.000 title 2
- 108091007433 antigens Proteins 0.000 title 2
- 238000003745 diagnosis Methods 0.000 title 1
- 201000004792 malaria Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15786488A | 1988-02-19 | 1988-02-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR8900697A true BR8900697A (pt) | 1989-10-17 |
Family
ID=22565606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR898900697A BR8900697A (pt) | 1988-02-19 | 1989-02-17 | Proteina de antigeno circunsporozoitico;composicao de vacina;composicao utilizavel para o diagnostico de malaria em seres humanos;processo para a producao da proteina de antigeno circunsporozoitico;sistema de vetor baculovirus-celula de inseto |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0329257A3 (pt) |
JP (1) | JPH025888A (pt) |
KR (1) | KR890013181A (pt) |
AU (1) | AU625713B2 (pt) |
BR (1) | BR8900697A (pt) |
IL (1) | IL89313A0 (pt) |
ZA (1) | ZA891169B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9002512D0 (en) * | 1990-02-05 | 1990-04-04 | 3I Res Expl Ltd | Polypeptides and dna encoding same |
CA2037151A1 (en) * | 1990-03-23 | 1991-09-24 | F. Hoffmann-La Roche Ag | Plasmodium sporozoite antigen |
US6855316B1 (en) | 1994-02-14 | 2005-02-15 | University Of Hawaii | Baculovirus produced Plasmodium falciparum vaccine |
US6420523B1 (en) * | 1992-04-13 | 2002-07-16 | University Of Hawaii | Baculovirus produced plasmodium falciparum vaccine |
MXPA01008176A (es) | 1999-02-18 | 2002-08-30 | Rmf Dictagene Sa | Vacuna contra el paludismo. |
US7037681B2 (en) | 2000-02-08 | 2006-05-02 | University Of Hawaii | Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants |
US20030100106A1 (en) | 2000-02-08 | 2003-05-29 | Chang Sandra P. | Baculovirus produced Plasmodium falciparum vaccine |
AT501429B1 (de) * | 2004-11-23 | 2007-05-15 | Nessler Medizintechnik Gmbh | Verfahren zur durchkontaktierung |
JP4828312B2 (ja) * | 2006-06-05 | 2011-11-30 | 日本圧着端子製造株式会社 | 防水コネクタ |
US9169304B2 (en) | 2012-05-01 | 2015-10-27 | Pfenex Inc. | Process for purifying recombinant Plasmodium falciparum circumsporozoite protein |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8404378D0 (en) * | 1984-02-20 | 1984-03-28 | Biogen Nv | Dna sequence recombinant dna molecules |
JPS63167797A (ja) * | 1985-12-18 | 1988-07-11 | マイクロジエネシス,インコ−ポレイテイド | 選択された昆虫宿主細胞中で選択されたポリペプチドを製造する方法 |
EP0278941A1 (en) * | 1987-01-30 | 1988-08-17 | Smithkline Biologicals S.A. | Expression of the P. falciparum circumsporozoite protein by yeast |
IL85905A0 (en) * | 1987-03-30 | 1988-09-30 | Univ New York | Immunogenic recombinant yeast expression product and method for purifying it |
-
1989
- 1989-02-14 AU AU29924/89A patent/AU625713B2/en not_active Ceased
- 1989-02-15 ZA ZA891169A patent/ZA891169B/xx unknown
- 1989-02-16 JP JP1037287A patent/JPH025888A/ja active Pending
- 1989-02-16 IL IL89313A patent/IL89313A0/xx unknown
- 1989-02-17 KR KR1019890001837A patent/KR890013181A/ko not_active Application Discontinuation
- 1989-02-17 BR BR898900697A patent/BR8900697A/pt not_active Application Discontinuation
- 1989-02-17 EP EP89200394A patent/EP0329257A3/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0329257A2 (en) | 1989-08-23 |
KR890013181A (ko) | 1989-09-21 |
ZA891169B (en) | 1989-11-29 |
IL89313A0 (en) | 1989-09-10 |
EP0329257A3 (en) | 1990-05-30 |
JPH025888A (ja) | 1990-01-10 |
AU2992489A (en) | 1989-08-24 |
AU625713B2 (en) | 1992-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT100900A (pt) | Processo para a preparacao de peptidos conjugados, e peptidos assim obtidos | |
NO922005D0 (no) | Farmasoeytiske preparater | |
MX164971B (es) | Procedimiento para la preparacion de conjugados de medicamentos citoxicos | |
KR900011476A (ko) | 백신 제제 | |
PT92487A (pt) | Processo para a preparacao de derivados de peptidos | |
PT98944A (pt) | Processo de preparacao de anticorpos alterados e de composicoes farmaceuticas para a prevencao e tratamento de infeccoes | |
PT88261A (pt) | Processo para a preparacao de nucleosidos com efeito terapeutico | |
DK89090A (da) | Farmaceutisk praeparat | |
DK489189D0 (da) | Farmaceutisk praeparat | |
ATA293589A (de) | Neue chinolinsulfonaminoderivate und verfahren zu deren herstellung sowie pharmazeutische zusammensetzung | |
DK705488A (da) | Farmaceutisk praeparat | |
BR9206785A (pt) | Bolsa para sangue e processo para sua produção | |
PT82651B (pt) | Processo para a preparacao de vacinas sintenticas para a febre aftosa a base de peptideos | |
PT92213A (pt) | Processo para a preparacao de conjugados de anticorpo-droga | |
BR9103036A (pt) | Composto,formulacao farmaceutica e processo para a preparacao do composto | |
BR8900697A (pt) | Proteina de antigeno circunsporozoitico;composicao de vacina;composicao utilizavel para o diagnostico de malaria em seres humanos;processo para a producao da proteina de antigeno circunsporozoitico;sistema de vetor baculovirus-celula de inseto | |
BR9206950A (pt) | Composição farmacêutica e processo para sua preparação | |
PT89955A (pt) | Processo para a preparacao de acidos 1-ciclopropil-quinolonocarboxilicos e seus derivados, e de n-ciclopropilanilinas utilizadas nesse processo | |
PT95656A (pt) | Dispositivo de dupla extremidade para aplicacao e medicao de drogas | |
PT97550A (pt) | Processo para a preparacao de uma composicao farmaceutica contendo ibuprofeno, e uma prostaglandina | |
DK603988D0 (da) | Farmaceutisk praeparat | |
DK496889D0 (da) | Peptidholdigt farmaceutisk praeparat | |
KR890700358A (ko) | 인체 종양관련 항원 | |
PT90524A (pt) | Processo e dispositivo para o registo de artigos | |
BR8806332A (pt) | Pigmentos monoazoicos,processo para sua preparacao e sua aplicacao |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Decision: refusal | ||
B15K | Others concerning applications: alteration of classification |
Ipc: C12N 15/00 (2006.01), C12R 1/90 (2006.01), G01N 33 |
|
B15K | Others concerning applications: alteration of classification |
Ipc: C12N 15/86 (2006.01), C07K 14/445 (2006.0 |